Your browser doesn't support javascript.
loading
PCSK9 inhibitors in clinical practice: Novel directions and new experiences.
Rallidis, Loukianos S; Skoumas, Ioannis; Liberopoulos, Evangelos N; Vlachopoulos, Charalambos; Kiouri, Estela; Koutagiar, Iosif; Anastasiou, Georgia; Kosmas, Nikolaos; Elisaf, Moses S; Tousoulis, Dimitrios; Iliodromitis, Efstathios.
Afiliação
  • Rallidis LS; 2nd Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece. Electronic address: lrallidis@gmail.com.
  • Skoumas I; 1st Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece.
  • Liberopoulos EN; Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece.
  • Vlachopoulos C; 1st Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece.
  • Kiouri E; 2nd Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.
  • Koutagiar I; 1st Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece.
  • Anastasiou G; Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece.
  • Kosmas N; 2nd Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.
  • Elisaf MS; Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece.
  • Tousoulis D; 1st Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece.
  • Iliodromitis E; 2nd Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.
Hellenic J Cardiol ; 61(4): 241-245, 2020.
Article em En | MEDLINE | ID: mdl-31783124

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Hipercolesterolemia / Hiperlipoproteinemia Tipo II Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Hellenic J Cardiol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Hipercolesterolemia / Hiperlipoproteinemia Tipo II Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Hellenic J Cardiol Ano de publicação: 2020 Tipo de documento: Article